117 related articles for article (PubMed ID: 38411280)
1. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression.
Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK
J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280
[TBL] [Abstract][Full Text] [Related]
2. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
[TBL] [Abstract][Full Text] [Related]
3. c-Src/Cav1-dependent activation of the EGFR by Dsg2.
Overmiller AM; McGuinn KP; Roberts BJ; Cooper F; Brennan-Crispi DM; Deguchi T; Peltonen S; Wahl JK; Mahoney MG
Oncotarget; 2016 Jun; 7(25):37536-37555. PubMed ID: 26918609
[TBL] [Abstract][Full Text] [Related]
4. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells.
Hütz K; Zeiler J; Sachs L; Ormanns S; Spindler V
Mol Carcinog; 2017 Aug; 56(8):1884-1895. PubMed ID: 28277619
[TBL] [Abstract][Full Text] [Related]
5. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC
BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389
[TBL] [Abstract][Full Text] [Related]
6. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
[TBL] [Abstract][Full Text] [Related]
7. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S
J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467
[TBL] [Abstract][Full Text] [Related]
8. Serine/Threonine Kinase (STK) 33 promotes the proliferation and metastasis of human esophageal squamous cell carcinoma via inflammation-related pathway.
Jiang H; Li L; Ma T; Wang R; Chen X; Xu K; Chen C; Liu Z; Wang H; Huang L
Pathol Res Pract; 2024 Feb; 254():155154. PubMed ID: 38286054
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic SNORD12B activates the AKT-mTOR-4EBP1 signaling in esophageal squamous cell carcinoma via nucleus partitioning of PP-1α.
Tian B; Liu J; Zhang N; Song Y; Xu Y; Xie M; Wang B; Hua H; Shen Y; Li Y; Yang M
Oncogene; 2021 May; 40(21):3734-3747. PubMed ID: 33941854
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
[TBL] [Abstract][Full Text] [Related]
12. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
[TBL] [Abstract][Full Text] [Related]
13. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
[TBL] [Abstract][Full Text] [Related]
14. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
[TBL] [Abstract][Full Text] [Related]
15. Significance of desmoglein-2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer.
Zhou BX; Li Y
Kaohsiung J Med Sci; 2020 May; 36(5):336-343. PubMed ID: 31930774
[TBL] [Abstract][Full Text] [Related]
16. WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.
Chai DM; Qin YZ; Wu SW; Ma L; Tan YY; Yong X; Wang XL; Wang ZP; Tao YS
J Exp Clin Cancer Res; 2019 Feb; 38(1):102. PubMed ID: 30808397
[TBL] [Abstract][Full Text] [Related]
17. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Zheng L; Zhao Z; Rong L; Xue L; Song Y
J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
[TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.
Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786
[TBL] [Abstract][Full Text] [Related]
20. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]